Российский кардиологический журнал (Dec 2018)
Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
- G. R. Galstyan,
- A. S. Galyavich,
- E. N. Grineva,
- V. S. Gurevich,
- M. V. Ezhov,
- V. Yu. Kalashnikov,
- Yu. A. Karpov,
- A. M. Mkrtumyan,
- S. V. Nedogoda,
- O. G. Smolenskaya,
- E. V. Shlyakhto,
- A. N. Yakovlev
Affiliations
- G. R. Galstyan
- National Medical Research Center for Endocrinology
- A. S. Galyavich
- Kazan State Medical University
- E. N. Grineva
- Almazov National Medical Research Center
- V. S. Gurevich
- St. Petersburg State University; I. I. Mechnikov NorthWestern State Medical University
- M. V. Ezhov
- National Medical Research Center of Cardiology of the Ministry of Health
- V. Yu. Kalashnikov
- National Medical Research Center for Endocrinology
- Yu. A. Karpov
- National Medical Research Center of Cardiology of the Ministry of Health
- A. M. Mkrtumyan
- A. I. Evdokimov Moscow State University of Medicine
- S. V. Nedogoda
- Volgograd State Medical University
- O. G. Smolenskaya
- Ural State Medical University
- E. V. Shlyakhto
- Almazov National Medical Research Center
- A. N. Yakovlev
- Almazov National Medical Research Center
- Journal volume & issue
-
Vol. 0,
no. 12
pp. 103 – 106
